Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Journal of Experimental & Clinical Cancer Research : CR|February 5, 2025
Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patientsAmalia Azzariti, Simona De Summa, Tommaso M Marvulli, et al.Frontiers in Molecular Biosciences|March 22, 2021
The Genetic Germline Background of Single and Multiple Primary MelanomasSimona De Summa, Antonia Lasorella, Sabino Strippoli, et al.Frontiers in Oncology|October 4, 2021
Electrochemotherapy as a Trigger to Overcome Primary Resistance to Anti-PD-1 Treatment: A Case Report of Melanoma of the ScalpDavide Quaresmini, Alessandra Di Lauro, Livia Fucci, et al.Journal of Surgical Oncology|May 10, 2016
Local treatment with electrochemotherapy of superficial angiosarcomas: Efficacy and safety results from a multi-institutional retrospective studyMichele Guida, Luca G Campana, Pietro Curatolo, et al.Molecular Cancer|January 19, 2022
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanomaSimona Serratì, Michele Guida, Roberta Di Fonte, et al.Journal of Translational Medicine|January 28, 2015
Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapyLetizia Porcelli, Gabriella Guida, Anna E Quatrale, et al.Cancers|October 17, 2019
The Management of Oligoprogression in the Landscape of New Therapies for Metastatic MelanomaMichele Guida, Nicola Bartolomeo, Ivana De Risi, et al.BMC Cancer|May 12, 2018
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)Michele Guida, Stefania Tommasi, Sabino Strippoli, et al.Journal of Experimental & Clinical Cancer Research : CR|September 27, 2023
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanomaSimona Serratì, Roberta Di Fonte, Letizia Porcelli, et al.Pharmacological Research|June 25, 2022
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapyLetizia Porcelli, Roberta Di Fonte, Ciro L Pierri, et al.Pageof 6